Deep Intelligent Pharma (DIP) Raises Nearly 50 Million USD in Series D Financing
The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Singapore, December 24, 2025 — Deep Intelligent Pharma (DIP), a global leader in AI-driven drug R&D platforms, announced the completion of… Read More »Deep Intelligent Pharma (DIP) Raises Nearly 50 Million USD in Series D Financing





